This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Forbes, N. S. Articles by Jain, R. K. Search for Related Content PubMed PubMed Citation Articles by Forbes, N. S. Articles by Jain, R. K.

Sparse Initial Entrapment of Systemically Injected Salmonella typhimurium Leads to Heterogeneous Accumulation within Tumors¹

E. L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114

Blood-borne therapeutics, which rely on diffusion and convection for delivery, often do not accumulate in effective concentrations distant from vasculature and are therefore unable to eradicate all cells within a tumor. Motile bacteria have the potential to overcome the diffusion and pressure gradients that prevent passive materials from penetrating into poorly perfused regions of tumors. Here, we test several proposed mechanisms of Salmonella typhimurium accumulation in tumors, including: (a) entrapment in the chaotic vasculature of tumors; (b) attraction to specific tumor microenvironments; and (c) preferential replication within specific microenvironments. After systemic injection of S. typhimurium into tumor-bearing mice, we used intravital microscopy and histological techniques to quantify their interaction with tumor vasculature. Immediately after injection, few S. typhimurium (<4 in 10,000) adhered to tumor vasculature; most remained passively suspended in the blood. Despite this low initial adhesion, 10,000-fold more S. typhimurium accumulated in tumors than any other organ 1 week after the injection, thus demonstrating their specificity. However, within the tumors, we found that most bacteria were located in necrotic tissue as large colonies far (750 µm) from functional vasculature. Together, these results suggest that S. typhimurium has limited ability to adhere to tumor vasculature and migrate within tumors and only survives in tissue that becomes necrotic. Although S. typhimurium is a promising delivery vehicle because of its tumor specificity, increasing its intra-tumoral motility should improve its therapeutic effectiveness.

This article has been cited by other articles:

				N. Arrach, M. Zhao, S. Porwollik, R. M. Hoffman, and M. McClelland Salmonella Promoters Preferentially Activated Inside Tumors Cancer Res., June 15, 2008; 68(12): 4827 - 4832. [Abstract] [Full Text] [PDF]

				K. Westphal, S. Leschner, J. Jablonska, H. Loessner, and S. Weiss Containment of Tumor-Colonizing Bacteria by Host Neutrophils Cancer Res., April 15, 2008; 68(8): 2952 - 2960. [Abstract] [Full Text] [PDF]

				R. W. Kasinskas and N. S. Forbes Salmonella typhimurium Lacking Ribose Chemoreceptors Localize in Tumor Quiescence and Induce Apoptosis Cancer Res., April 1, 2007; 67(7): 3201 - 3209. [Abstract] [Full Text] [PDF]

				M. Zhao, M. Yang, H. Ma, X. Li, X. Tan, S. Li, Z. Yang, and R. M. Hoffman Targeted therapy with a salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res., August 1, 2006; 66(15): 7647 - 7652. [Abstract] [Full Text] [PDF]

				F. Avogadri, C. Martinoli, L. Petrovska, C. Chiodoni, P. Transidico, V. Bronte, R. Longhi, M. P. Colombo, G. Dougan, and M. Rescigno Cancer Immunotherapy Based on Killing of Salmonella-Infected Tumor Cells Cancer Res., May 1, 2005; 65(9): 3920 - 3927. [Abstract] [Full Text] [PDF]